At a glance
- Originator Nonindustrial source
- Class Antiepileptic drugs; Neuroprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Epilepsy
Most Recent Events
- 30 Jun 1999 New profile
- 30 Jun 1999 Preclinical development for Epilepsy in Belgium (Unknown route)